QA: Viracta Therapeutics Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001061027_2023_Viracta_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001061027, Viracta Therapeutics Inc

  xvar xval
0 AssetsCurrent 93,747,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 148,000
3 remainder_Assets 2,096,000
4 LiabilitiesCurrent 10,011,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 24,370,937
9 ResearchAndDevelopmentExpense 30,944,029
10 remainder_Expenses -51,217
11 remainder_Revenues 23,092
12 remainder_NetIncome 1,252,814
13 remainder_ComprehensiveNetIncome -136,965
  yvar yval
0 Assets 95,991,000
1 Liabilities 10,011,000
2 Expenses 55,263,749
3 Revenues 23,092
4 StockholdersEquity 85,980,000
5 NetIncome -53,987,843
6 ComprehensiveNetIncome -54,056,326
7 BaseVar 81,339,310
8 EconomicCapitalRatiobeforeLimitedLiability 2.52
9 EconomicCapitalRatio 3.37

Edgar->Model Mapping

Feature Distribution

Change over Time